arrow
A

Arleigh McCurdy

ottawa hospital research institute
H指数:19
被引数:3,103

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Challenges of Conducting a Feasibility Pilot Randomized Controlled Trial During COVID-19 Restrictions: Rivaroxaban Versus Acetyl Salicylic Acid in Patients with Multiple Myeloma on Lenalidomide-Based Therapy (RithMM)

在COVID-19限制期间开展可行性试点随机对照试验的挑战:利伐沙班与乙酰水杨酸在应用来那度胺为基础治疗的骨髓瘤患者中的比较(RithMM)

2026-10-220
OA
Immunogenicity and Safety of a Third and Subsequent COVID-19 Vaccine Doses in Patients with Plasma Cell Dyscrasias

第三剂及后续剂次的COVID-19疫苗在浆细胞疾病患者中的免疫原性和安全性

2026-02-170
OAAI
The impact of age on survival and excess mortality after autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients

年龄对初诊多发性骨髓瘤患者自体造血细胞移植后生存和超额死亡率的影响

2026-01-011
OA
Real-World Outcomes In Myeloma Patients With t (11;14): A Matched Comparison Using the Canadian Myeloma Research Group National Clinical Database

t(11;14)骨髓瘤患者的真实世界结局:一项基于加拿大骨髓瘤研究组国家临床数据库的匹配比较研究

2025-11-040
PRE
Salvage autologous stem cell transplantation outcomes and the use of maintenance in relapsed multiple myeloma: Real world evidence from the Canadian Myeloma Research Group Database

自体干细胞移植的挽救性治疗结果及在复发多发性骨髓瘤中维持治疗的应用:来自加拿大骨髓瘤研究组数据库的真实世界证据

2025-10-310
PRE
Changes in Frailty Categorization Over One Year among Real-World Patients with Multiple Myeloma: A Prospective Cohort Study (MFRAIL)

一年内真实世界多发性骨髓瘤患者脆弱性分类的变化:一项前瞻性队列研究(MFRAIL)

2025-09-110
PRE
Incidence and prevalence of clinically detected smoldering multiple myeloma within the general population: a retrospective observational cohort study

临床检测到的无症状多发性骨髓瘤在普通人群中的发病率和患病率:一项回顾性观察性队列研究

2025-08-290
OAAI
Treatment Patterns and Outcomes of Multiple Myeloma Patients Undergoing Second-Line Therapy: A Canadian Myeloma Research Group (CMRG) Analysis

多发性骨髓瘤患者接受二线治疗的治疗模式与结局:加拿大骨髓瘤研究组(CMRG)分析

2025-02-270
PRE
Tandem Autologous Stem Cell Transplantation Does Not Benefit fi t High-Risk Myeloma Patients in the Maintenance Era: Real-World Results from The Canadian Myeloma Research Group Database
2024-09-011
PRE
Comparing the clinical trial efficacy versus real-world effectiveness of treatments for multiple myeloma: a population-based study

比较多发性骨髓瘤治疗的临床试验疗效与实际疗效: 一项基于人群的研究

2024-08-220
OAAI
Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (WBMT)
2024-08-193
OAAI
Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database
2023-12-083
OAAI
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database
2023-09-056
OAAI